SU2C Awards New Innovative Grants

The multi-partner non-profit cancer research initiative has funded new high-risk, high-reward grants using exome sequencing, genomic analysis, and tumor-specific drug response studies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.